PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Effect of Ivermectin on time to resolution of symptoms among adults with mild COVID-19

2021-03-04
(Press-News.org) What The Study Did: This randomized clinical trials reports that among adults with mild COVID-19, a five-day course of ivermectin, compared with placebo, didn't significantly improve the time to resolution of symptoms. The findings don't support the use of ivermectin for treatment of mild COVID-19, although larger trials may be needed to understand the effects of ivermectin on other clinically relevant outcomes.

Authors: Eduardo López-Medina, M.D., M.Sc., of the Centro de Estudios en Infectología Pediátrica in  Cali, Colombia, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jama.2021.3071)

Editor's Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

INFORMATION:

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.3071?guestAccessKey=e98010ef-e747-40ad-b865-a18c9c0450d9&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=030421



ELSE PRESS RELEASES FROM THIS DATE:

COVID-19 in 2021

2021-03-04
What The Article Says: Current best evidence about COVID-19 vaccines, immunity and whether SARS-CoV-2 will become an endemic or seasonal virus is summarized in this Viewpoint. Authors: Carlos del Rio, M.D., of the Emory University School of Medicine in Atlanta, is the corresponding author. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jama.2021.3760) Editor's Note: The article includes conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support. INFORMATION: Media advisory: The full article is linked to this news release. Embed ...

By detecting genetic material, fast sensor has potential use as a clinical tool

2021-03-04
In less than a second, a small sensor used in brain chemistry research can detect the key molecules that provide the genetic instructions for life, RNA and DNA, a new study from American University shows. The AU researchers believe the sensor is a useful tool for scientists engaged in clinical research to measure DNA metabolism, and that the sensor could be a quick way for lab clinicians to distinguish 'healthy' from 'sick' samples and determine if a pathogen is fungal, bacterial, or viral, before conducting further analysis. To explore whether the sensors could detect RNA and DNA, ...

Fermented wool is the answer

Fermented wool is the answer
2021-03-04
The Pazyryk carpet is the world's oldest example of a knotted-pile carpet and is kept at the State Hermitage Museum in St. Petersburg, Russia. The carpet, which was made out of new wool at around 400 BC, is one of the most exciting examples of central Asian craftsmanship from the Iron Age. Ever since the carpet was discovered in 1947 by Russian archaeologists in a kurgan tomb in the Altai mountains, experts in traditional dyeing techniques have been puzzled by the vivid red, yellow and blue colours of the carpet, which lay buried in extreme conditions for almost two thousand five hundred years. Red fibres ...

Citizen science study captures 2.2M wildlife images in NC

2021-03-04
You didn't need a Ph.D. to contribute to research into wildlife abundance and behavior in North Carolina, thanks to a large-scale citizen science project led by North Carolina State University researchers. Through the project, called North Carolina Candid Critters, researchers trained 580 volunteers to take candid animal photos with heat sensitive cameras, and then share their photos through a website called eMammal. In an article on the project in the journal Citizen Science: Theory and Practice, researchers reported on the successes and challenges of the effort, which gathered more than 2.2 million wildlife photos across three years, and increased the number of verified mammal records that were available in the state by a factor of five. "The power of this is that you can get ...

Approaches for optimal use of different COVID-19 vaccines

2021-03-04
What The Article Says: This Viewpoint proposes ways to maximize vaccine efficacy and allocation given the rise of coronavirus variants and authorization of a Johnson & Johnson vaccine, including reserving the latter for younger healthier populations, boosting it with a single-dose messenger RNA (mRNA) vaccination and single mRNA immunization of people with prior documented SARS-CoV-2 infection. Authors: John P. Moore, Ph.D., of Weill Cornell Medicine in New York, is the corresponding author. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jama.2021.3465) Editor's Note: The article includes an Editor's Note. Please see the article for additional information, including other authors, author ...

Antisense oligonucleotides as a feasible therapy to treat MECP2 dupli

2021-03-04
Many cognitive neurodevelopmental disorders are a result of too many or too few copies of certain genes or chromosomes. To date, no treatment options exist for this class of disorders. MECP2 duplication syndrome (MDS) is one such disorder that primarily affects boys and results from a duplication spanning the methyl-CpG binding protein 2 (MECP2) locus located on the X chromosome. A preclinical study published from the laboratory of Dr. Huda Zoghbi, professor at Baylor College of Medicine and director of the Jan and Dan Duncan Neurological Research Institute at Texas Children's Hospital, provides experimental evidence that supports the use of antisense oligonucleotides as ...

Artificial intelligence reveals current drugs that may help combat Alzheimer's disease

2021-03-04
BOSTON - New treatments for Alzheimer's disease are desperately needed, but numerous clinical trials of investigational drugs have failed to generate promising options. Now a team at Massachusetts General Hospital (MGH) and Harvard Medical School (HMS) has developed an artificial intelligence-based method to screen currently available medications as possible treatments for Alzheimer's disease. The method could represent a rapid and inexpensive way to repurpose existing therapies into new treatments for this progressive, debilitating neurodegenerative condition. ...

Newly discovered millipede, Nannaria hokie, lives at Virginia Tech

Newly discovered millipede, Nannaria hokie, lives at Virginia Tech
2021-03-04
Hearing the words "new species discovered" may conjure images of deep caves, uncharted rainforests, or hidden oases in the desert. But the reality is that thousands of new species are discovered each year by enterprising scientists all over the world. Many of these new species do come from exotic locations, but more surprisingly, many come from just down the road, including the newest member of the Hokie Nation, the millipede Nannaria hokie. The newest Hokie -- which has about 60 more legs than the HokieBird ­-- was discovered living under rocks by the Duck Pond behind the Grove on Virginia Tech's Blacksburg campus. Since then, the critter has been found at the area commonly referred to as stadium ...

New evidence COVID-19 antibodies, vaccines less effective against variants

New evidence COVID-19 antibodies, vaccines less effective against variants
2021-03-04
New research at Washington University School of Medicine in St. Louis indicates that three new, fast-spreading variants of the virus that cause COVID-19 can evade antibodies that work against the original form of the virus that sparked the pandemic. With few exceptions, whether such antibodies were produced in response to vaccination or natural infection, or were purified antibodies intended for use as drugs, the researchers found more antibody is needed to neutralize the new variants. The findings, from laboratory-based experiments and published March 4 in Nature Medicine, suggest that COVID-19 drugs and vaccines developed thus far may become less effective ...

Smoking cessation drug may treat Parkinson's in women

2021-03-04
Texas A&M University College of Medicine ressearchers have recently discovered that cytisine -- a smoking cessation drug commonly used in Europe -- reduces the loss of dopamine neurons in females. These findings provide potential evidence for the use of the drug to treat Parkinson's disease or stop its progression in women. Sara Zarate and Gauri Pandey, graduate students from the lab of Rahul Srinivasan, assistant professor in the Department of Neuroscience & Experimental Therapeutics, are co-first authors of the research. Their findings are published in the Journal of Neurochemistry. There ...

LAST 30 PRESS RELEASES:

The puberty talk: Parents split on right age to talk about body changes with kids

Tusi (a mixture of ketamine and other drugs) is on the rise among NYC nightclub attendees

Father’s mental health can impact children for years

Scientists can tell healthy and cancerous cells apart by how they move

Male athletes need higher BMI to define overweight or obesity

How thoughts influence what the eyes see

Unlocking the genetic basis of adaptive evolution: study reveals complex chromosomal rearrangements in a stick insect

Research Spotlight: Using artificial intelligence to reveal the neural dynamics of human conversation

Could opioid laws help curb domestic violence? New USF research says yes

NPS Applied Math Professor Wei Kang named 2025 SIAM Fellow

Scientists identify agent of transformation in protein blobs that morph from liquid to solid

Throwing a ‘spanner in the works’ of our cells’ machinery could help fight cancer, fatty liver disease… and hair loss

Research identifies key enzyme target to fight deadly brain cancers

New study unveils volcanic history and clues to ancient life on Mars

Monell Center study identifies GLP-1 therapies as a possible treatment for rare genetic disorder Bardet-Biedl syndrome

Scientists probe the mystery of Titan’s missing deltas

Q&A: What makes an ‘accidental dictator’ in the workplace?

Lehigh University water scientist Arup K. SenGupta honored with ASCE Freese Award and Lecture

Study highlights gaps in firearm suicide prevention among women

People with medical debt five times more likely to not receive mental health care treatment

Hydronidone for the treatment of liver fibrosis associated with chronic hepatitis B

Rise in claim denial rates for cancer-related advanced genetic testing

Legalizing youth-friendly cannabis edibles and extracts and adolescent cannabis use

Medical debt and forgone mental health care due to cost among adults

Colder temperatures increase gastroenteritis risk in Rohingya refugee camps

Acyclovir-induced nephrotoxicity: Protective potential of N-acetylcysteine

Inhibition of cyclooxygenase-2 upregulates the nuclear factor erythroid 2-related factor 2 signaling pathway to mitigate hepatocyte ferroptosis in chronic liver injury

AERA announces winners of the 2025 Palmer O. Johnson Memorial Award

Mapping minds: The neural fingerprint of team flow dynamics

Patients support AI as radiologist backup in screening mammography

[Press-News.org] Effect of Ivermectin on time to resolution of symptoms among adults with mild COVID-19